5 Key Takeaways

• 1

  The skin fluorescent imaging (SFI) system offers non-invasive molecular testing for difficult-to-characterize moles, potentially reducing unnecessary biopsies.

• 2

  SFI identifies biological tissue remodeling associated with melanoma, providing molecular information that enhances decision-making in lesion assessment.

• 3

  In a study of 251 subjects, SFI demonstrated 100% detection of oncogenic activity in melanoma cases, indicating high likelihood for melanoma development.

• 4

  The SFI system achieved an AUC of 0.907, indicating solid discriminatory performance in distinguishing lesions undergoing melanoma-related remodeling.

• 5

  SFI complements dermoscopy by providing non-invasive biological information, improving the accuracy of lesion evaluations and biopsy decisions.